Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium

39Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Prostate-specific membrane antigen (PSMA), a well-known biomarker of prostate cancer, has also been found to be highly expressed in the neovasculature of multiple non-prostatic solid tumors. As a consequence, it has the potential to become a biomarker for tumor-associated vasculature. Herein, we describe an in vitro model for assessing PSMA expression associated with tube formation by primary human umbilical vein endothelial cells (HUVECs) cultured in Matrigel and induced by tumor-conditioned medium (TCM) derived from human breast cancer cells (MDA-MB-231). In contrast to vascular endothelial growth factor (VEGF)-containing endothelial cell medium, TCM induced higher expression of PSMA in HUVECs. The vessel-like tubes were detected by imaging with fluorescent PSMA inhibitors. Consequently, this in vitro model is expected to enable subsequent studies aimed at determining the role of PSMA in angiogenesis and factors that induce it. Copyright © 2011 Spandidos Publications Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Liu, T., Jabbes, M., Nedrow-Byers, J. R., Wu, L. Y., Bryan, J. N., & Berkman, C. E. (2011). Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium. International Journal of Oncology, 38(5), 1349–1355. https://doi.org/10.3892/ijo.2011.946

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free